Non-Targeted Metabolomic Profiling of Coronary Heart Disease Patients With Taohong Siwu Decoction Treatment.

Tao, Tianqi; He, Tao; Mao, Huimin; Wu, Xudong; Liu, Xiuhua

Tao, Tianqi; He, Tao; Mao, Huimin; Wu, Xudong; Liu, Xiuhua.

Afiliación

Tao T; Department of Pathophysiology, Chinese PLA General Hospital, Beijing, China.
He T; Department of Pathophysiology, Chinese PLA General Hospital, Beijing, China.
Mao H; Department of Pathophysiology, Chinese PLA General Hospital, Beijing, China.
Wu X; Outpatient Department, Chinese PLA General Hospital, Beijing, China.
Liu X; Department of Pathophysiology, Chinese PLA General Hospital, Beijing, China.

Front Pharmacol ; 11: 651, 2020.

Article en En | MEDLINE | ID: mdl-32457630

Palabras clave

Taohong Siwu decoction; UPLC-MS/MS; coronary heart disease; metabolomics; randomized double-blind trial

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Medicinas Tradicionales: Medicinas_tradicionales_de_asia / Medicina_china Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google